FDA Authorizes Athletic Collar To Reduce Brain Injuries

The Q-Collar is meant to work by improving blood flow to the brain, and has been shown to reduce signs of trauma from head impacts when playing sports.

The Q-Collar is a C-shaped device worn around the neck increase blood flow to the brain and reduce its movement inside the skull
The Q-Collar is a C-shaped device worn around the neck to increase blood flow to the brain and reduce its movement inside the skull • Source: Q30 Sports Science

The US Food and Drug Administration has given marketing authorization to Q30 Sports Science’s Q-Collar device, which is intended to reduce traumatic brain injury (TBI).

On 26 February, the agency announced that it had given the nod to Q30’s de novo application for the device’s use in children as young as 13 to protect their brains from the effects of repetitive sub-concussive head impacts

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Business

More from Medtech Insight

Faster Device Certification Among Keys To Unlocking Innovation In EU MedTech Sector

 

While MedTech Europe sharpens its focus on what the EU most urgently needs to advance the medtech market in four targeted measures, the European Commission has also unveiled four priorities for 2025.

Will NICE’s New Medtech Evaluation Plans Hit the Target for Patients and Industry?

 
• By 

One year after the UK mooted the Rules-Based Pathway to give medtechs clarity on what can be expected from an evaluation, the devices industry says UK healthtech assessment and adoption processes are still failing to meet the needs of innovators and patients.

The Value Of Consumer Wearables Within The Clinic Is Currently Unknown, Says Cardiologist

 

“It’s quite likely [consumer wearable manufacturers] are changing the sensitivity and specificity based on consumer feedback, but not for medical reasons,” said Dipak Kotecha, a University of Birmingham professor of cardiology. Often, self-reported performance evidence from manufacturers is “low quality and biased.”